Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 570

1.
2.

Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.

Alinejad V, Hossein Somi M, Baradaran B, Akbarzadeh P, Atyabi F, Kazerooni H, Samadi Kafil H, Aghebati Maleki L, Siah Mansouri H, Yousefi M.

Biomed Pharmacother. 2016 Oct;83:229-240. doi: 10.1016/j.biopha.2016.06.037. Epub 2016 Jun 30.

PMID:
27372407
3.

Phospho-BRD4: transcription plasticity and drug targeting.

Chiang CM.

Drug Discov Today Technol. 2016 Mar;19:17-22. doi: 10.1016/j.ddtec.2016.05.003. Epub 2016 Jul 18. Review.

PMID:
27769352
4.

Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.

Sarisozen C, Dhokai S, Tsikudo EG, Luther E, Rachman IM, Torchilin VP.

Eur J Pharm Biopharm. 2016 Nov;108:54-67. doi: 10.1016/j.ejpb.2016.08.013. Epub 2016 Aug 26.

PMID:
27569031
5.

Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.

Kim BH, Yi EH, Ye SK.

Arch Pharm Res. 2016 Aug;39(8):1085-99. doi: 10.1007/s12272-016-0795-8. Epub 2016 Aug 11. Review.

PMID:
27515050
6.

A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.

Bisht S, Schlesinger M, Rupp A, Schubert R, Nolting J, Wenzel J, Holdenrieder S, Brossart P, Bendas G, Feldmann G.

J Nanobiotechnology. 2016 Jul 11;14(1):57. doi: 10.1186/s12951-016-0209-6.

7.

Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.

Marchwicka A, Cunningham A, Marcinkowska E, Brown G.

Expert Opin Ther Pat. 2016 Aug;26(8):957-71. doi: 10.1080/13543776.2016.1205586. Epub 2016 Jul 11. Review.

PMID:
27336223
8.

Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma.

Labala S, Jose A, Venuganti VV.

Colloids Surf B Biointerfaces. 2016 Oct 1;146:188-97. doi: 10.1016/j.colsurfb.2016.05.076. Epub 2016 Jun 3.

PMID:
27318964
9.
10.

Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes.

Chen Z, Zhang T, Wu B, Zhang X.

Int J Nanomedicine. 2016 Mar 11;11:991-1002. doi: 10.2147/IJN.S101872. eCollection 2016.

11.

Gold-conjugated resveratrol nanoparticles attenuate the invasion and MMP-9 and COX-2 expression in breast cancer cells.

Park SY, Chae SY, Park JO, Lee KJ, Park G.

Oncol Rep. 2016 Jun;35(6):3248-56. doi: 10.3892/or.2016.4716. Epub 2016 Mar 29.

PMID:
27035791
12.

Optimal sequence of antisense DNA to silence YB-1 in lung cancer by use of a novel polysaccharide drug delivery system.

Izumi H, Nagao S, Mochizuki S, Fujiwara N, Sakurai K, Morimoto Y.

Int J Oncol. 2016 Jun;48(6):2472-8. doi: 10.3892/ijo.2016.3451. Epub 2016 Mar 23.

PMID:
27035516
13.

Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways.

Ma K, Wang C, Geng Q, Fan Y, Ning J, Yang H, Dong X, Dong D, Guo Y, Wei X, Li E, Wu Y.

Oncol Rep. 2016 Jun;35(6):3505-13. doi: 10.3892/or.2016.4711. Epub 2016 Mar 28.

PMID:
27035232
14.

Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention.

Boakye CH, Patel K, Doddapaneni R, Bagde A, Behl G, Chowdhury N, Safe S, Singh M.

Colloids Surf B Biointerfaces. 2016 Jul 1;143:156-67. doi: 10.1016/j.colsurfb.2016.03.036. Epub 2016 Mar 15.

PMID:
27003466
15.

Fluorescence Characterization of Gold Modified Liposomes with Antisense N-myc DNA Bound to the Magnetisable Particles with Encapsulated Anticancer Drugs (Doxorubicin, Ellipticine and Etoposide).

Skalickova S, Nejdl L, Kudr J, Ruttkay-Nedecky B, Jimenez AM, Kopel P, Kremplova M, Masarik M, Stiborova M, Eckschlager T, Adam V, Kizek R.

Sensors (Basel). 2016 Feb 25;16(3):290. doi: 10.3390/s16030290.

16.

Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.

Li J, Zhang X, Wang M, Li X, Mu H, Wang A, Liu W, Li Y, Wu Z, Sun K.

Int J Pharm. 2016 Mar 30;501(1-2):112-23. doi: 10.1016/j.ijpharm.2016.01.068. Epub 2016 Jan 29.

PMID:
26828670
17.

Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer.

Wang Y, Liu T, Li H.

J Biomater Sci Polym Ed. 2016;27(7):545-56. doi: 10.1080/09205063.2015.1131667. Epub 2016 Mar 16.

PMID:
26786618
18.

Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model.

Zhou K, Nguyen LH, Miller JB, Yan Y, Kos P, Xiong H, Li L, Hao J, Minnig JT, Zhu H, Siegwart DJ.

Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):520-5. doi: 10.1073/pnas.1520756113. Epub 2016 Jan 4.

19.

Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.

Yu H, Guo C, Feng B, Liu J, Chen X, Wang D, Teng L, Li Y, Yin Q, Zhang Z, Li Y.

Theranostics. 2016 Jan 1;6(1):14-27. doi: 10.7150/thno.13515. eCollection 2016.

20.

Novel Morphologic and Genetic Analysis of Cancer Cells in a 3D Microenvironment Identifies STAT3 as a Regulator of Tumor Permeability Barrier Function.

Park MC, Jeong H, Son SH, Kim Y, Han D, Goughnour PC, Kang T, Kwon NH, Moon HE, Paek SH, Hwang D, Seol HJ, Nam DH, Kim S.

Cancer Res. 2016 Mar 1;76(5):1044-54. doi: 10.1158/0008-5472.CAN-14-2611. Epub 2015 Dec 16.

Supplemental Content

Loading ...
Support Center